Deep Track Capital, LP 13D and 13G filings for Apellis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-22 4:16 pm Sale | 2024-11-20 | 13G | Apellis Pharmaceuticals, Inc. APLS | Deep Track Capital, LP | 6,000,000 4.820% | -220,265 (-3.54%) | Filing |
| 2024-11-22 08:47 am Purchase | 2024-11-15 | 13G | Apellis Pharmaceuticals, Inc. APLS | Deep Track Capital, LP | 6,220,265 5.000% | 6,220,265 (New Position) | Filing |